When you combine buprenorphine treatment and counseling services, you tap into an integrated approach that addresses both your opioid use disorder and co-occurring mental health conditions. This model helps you manage withdrawal and cravings with medication while simultaneously working through anxiety, depression, trauma or PTSD in therapy. At Ascend Health, we lead in comprehensive mat and mental health care, offering personalized buprenorphine-based options—like Suboxone or Sublocade—paired with evidence-based counseling to support your whole-person recovery journey.
In this guide, you’ll discover:
- The fundamentals of buprenorphine therapy and formulations
- How counseling enhances recovery and mental health outcomes
- Key clinical evidence supporting combined treatment
- Steps to design a tailored dual diagnosis care plan
- Strategies for sustaining long-term healing
Whether you’re exploring an outpatient dual diagnosis mat program, considering a virtual dual diagnosis mat program or seeking a dual diagnosis mat center, you’ll gain clear, practical guidance at every stage.
Understanding buprenorphine treatment
Buprenorphine is a partial opioid agonist used in medication-assisted treatment (MAT) to manage opioid use disorder (OUD). By binding to the same receptors as full agonists (heroin, oxycodone) but with a ceiling effect, it reduces withdrawal and cravings without producing euphoria or heavy sedation. The World Health Organization recommends buprenorphine alongside methadone and naltrexone as first-line treatments for OUD, and it remains the most widely prescribed option due to its safety and flexibility [1].
Buprenorphine formulations
- Suboxone (buprenorphine/naloxone sublingual film or tablet)
- Subutex (buprenorphine-only sublingual tablet)
- Sublocade (monthly extended-release injection)
- Probuphine (six-month subdermal implant)
Each formulation offers distinct advantages. Sublocade and Probuphine reduce daily dosing decisions and improve adherence, while Suboxone’s naloxone component deters injection misuse [2].
Safety and side effects
Common side effects include headache, nausea, constipation and insomnia. Serious risks increase if you mix buprenorphine with other central nervous system depressants such as alcohol or benzodiazepines (Ativan, Xanax) due to additive respiratory depression [2]. To manage risks:
- Carry a naloxone kit for overdose reversal
- Inform all providers about your buprenorphine prescription
- Report any new medications or supplements
Special populations
- Pregnancy and breastfeeding: Buprenorphine and methadone are both considered safe and effective for pregnant or postpartum individuals, reducing neonatal abstinence severity [3].
- Adolescents: Providers may prescribe buprenorphine off-label with careful monitoring.
- Hepatic impairment: Dose adjustments may be necessary; discuss liver function testing with your clinician.
Integrating counseling services
Counseling is a critical component of effective buprenorphine treatment and counseling services. Therapy helps you address underlying mental health issues, develop coping strategies and build a support network. When combined with medication, counseling can:
- Improve retention and continuity of care
- Reduce the likelihood of relapse
- Enhance management of co-occurring disorders
- Foster motivation and self-efficacy
At Ascend Health, you can choose from an outpatient addiction and therapy combination or a mat program with individual counseling, depending on your needs.
Evidence-based therapy models
- Cognitive behavioral therapy (CBT)
- Dialectical behavior therapy (DBT)
- Motivational interviewing (MI)
- Interpersonal therapy (IPT)
These modalities help you identify and reframe unhelpful thoughts, regulate emotions, and improve interpersonal skills.
Family involvement
- Family therapy sessions to rebuild trust and communication
- Educational workshops for loved ones on OUD and MAT
- Support groups for family members
Peer support
- Recovery coaching
- Peer-led groups and 12-step facilitation
- Lived-experience mentors
Case management
- Assistance with housing, employment and legal challenges
- Coordination of medical, psychiatric and psychosocial services
- Referral to community resources and support services
Counseling frequency and outcomes
Clinical data confirm the value of combining buprenorphine with counseling:
- Attending at least three counseling sessions in the first three months reduces poor medication continuity by 17% (OR 0.83; 95% CI: 0.78–0.87) [4].
- Concurrent counseling leads to a 21% lower likelihood of treatment discontinuation over 12 months (OR 0.79; 95% CI: 0.75–0.83) [4].
- In dual cocaine-opioid dependence, higher psychotherapy attendance correlated with lower drug metabolite levels, notably at 16 mg buprenorphine dosing [5].
Clinical evidence for combined care
The synergy between medication and therapy yields tangible benefits. Key findings include:
| Study | Outcome | Reference |
|---|---|---|
| Buprenorphine ≥16 mg/day | Improved retention, reduced opioid use | PMC – NCBI |
| French outpatient program | <10% opioid-positive urine at 12 months | PMC – NCBI |
| Early counseling (3 months) | 17% lower poor continuity | PubMed |
| Year-long counseling | 21% lower discontinuation | PubMed |
These data underscore how adequate dosing and consistent therapy reduce relapse risk and support sustained abstinence.
Addressing mental health conditions
Co-occurring disorders like anxiety, depression and trauma often drive substance use. Your integrated program should explicitly target these issues.
Anxiety and depression
- Enroll in an outpatient suboxone program for anxiety or depression and addiction mat program.
- Combine SSRIs or SNRIs with CBT to rebalance neurotransmitters and reframe maladaptive thoughts.
- Track symptoms with GAD-7 or PHQ-9 scales to guide treatment adjustments.
Trauma and PTSD
- Seek trauma-informed care at centers offering suboxone-and-trauma-therapy-integration or trauma-informed-mat-treatment.
- Use EMDR or cognitive processing therapy to process traumatic memories safely.
- Build skills for grounding, distress tolerance and emotional regulation.
Psychiatric support
For complex mental health presentations, collaborate with psychiatry:
- Programs featuring suboxone treatment with psychiatric support integrate medication management for mood or psychotic disorders.
- Psychiatrists can prescribe adjunctive medications (mood stabilizers, antipsychotics) and coordinate care to prevent drug interactions.
Designing an integrated program
Selecting a dual diagnosis mat center with seamless coordination ensures your care team works in harmony.
Coordinated care model
At Ascend Health, our integrated behavioral health and mat services include:
- Joint intake by addiction specialists and mental health clinicians
- Unified treatment goals across medication, therapy and case management
- Regular interdisciplinary team meetings to review progress
Accreditation and quality metrics
We maintain accreditation and track outcomes such as:
- Treatment retention rates
- Urine toxicology results
- Patient-reported symptom improvements
Transparent metrics help refine your plan and demonstrate our commitment to evidence-based excellence.
Virtual and telehealth options
To increase access and convenience, Ascend Health offers:
- Teletherapy and e-consults
- Remote medication monitoring
- A fully online virtual dual diagnosis mat program
These options reduce travel barriers and maintain continuity during life transitions.
Getting started with care
Beginning buprenorphine treatment and counseling services involves several steps:
Finding a provider
- Verify DATA-2000 waiver credentials for buprenorphine prescribing
- Ask about integrated services like a co occurring disorders treatment with suboxone or a suboxone program with mental health therapy
- Confirm availability of counseling, case management and psychiatric support
Preparing for your appointment
Bring:
- A complete medical and psychiatric history
- Recent substance use and withdrawal timeline
- Insurance information and ID
- A list of current medications and supplements
Be ready to discuss your goals, prior treatment experiences and any legal or social challenges.
Insurance and financing
- Many plans cover MAT and therapy; Ascend Health’s billing team assists with prior authorizations.
- Sliding scale or grant funding may be available for uninsured or underinsured clients.
- Medicaid and Medicare often cover buprenorphine and counseling services.
Sustaining your recovery
Long-term success hinges on ongoing support, relapse prevention and self-care.
Relapse prevention planning
- Identify high-risk situations and develop coping strategies
- Create an emergency response plan with trusted contacts
- Schedule booster sessions in therapy when stressors arise
Wellness and holistic practices
- Incorporate regular exercise, balanced nutrition and sleep hygiene
- Practice mindfulness, yoga or meditation to reduce stress
- Explore art, music or equine therapy as creative outlets
Technology and apps
- Use recovery apps for medication reminders and mood tracking
- Join online peer forums for 24/7 support
- Leverage telehealth for quick check-ins with your team
Community involvement
- Attend peer-led or professionally facilitated support groups
- Volunteer or participate in community activities to build social capital
- Engage family and friends in your recovery journey
If you face obstacles, your Ascend Health team can revisit your comprehensive mat and mental health care plan, adjust dosing or explore alternatives like sublocade treatment with behavioral therapy.
Conclusion
Buprenorphine treatment and counseling services form a powerful, evidence-based alliance that addresses both your opioid use disorder and mental health needs. By choosing an integrated care provider like Ascend Health, you benefit from coordinated medication management, expert therapy and ongoing support tailored to your unique journey. With this comprehensive approach, you’re empowered to reduce cravings, manage co-occurring conditions and build a stable foundation for lasting recovery.
References
- (PMC – NCBI)
- (CAMH)
- (SAMHSA)
- (PubMed)
- (PMC – NCBI)



